Results 181 to 190 of about 7,219 (278)
Macrophage: Biological Functions, Diseases, and Therapeutic Targets
Macrophages are sentinel innate immune cells that arise from embryonic precursors and bone marrow monocytes, displaying a functional continuum that transcends the classical M1 (pro‐inflammatory)/M2 (anti‐inflammatory) dichotomy. Under homeostatic conditions, balanced M1/M2 polarization preserves tissue integrity by coordinating immune surveillance ...
Bihang Sun +4 more
wiley +1 more source
The Effects of Sodium-glucose Cotransporter 2 Inhibitors on Serum Sodium in Patients With Type 2 Diabetes: A Real-World Study. [PDF]
Steinmetz T +10 more
europepmc +1 more source
Encounters With Traditional Medicine and Further Multidisciplinary and International Cooperation
ABSTRACT Background The integration of traditional medicine (TM) into modern healthcare has gained global momentum. Following the inclusion of TM in the 11th revision of the International Classification of Diseases, multidisciplinary and international cooperation has become increasingly essential.
Kokoro Ichihara +6 more
wiley +1 more source
Corticosteroids (glucocorticoids and mineralocorticoids) [PDF]
Derek G. Waller, Anthony P. Sampson
core +1 more source
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
Gulalai Tariq +2 more
wiley +1 more source
Abstract Purpose Assessing the 24‐month treatment outcome of half‐dose photodynamic therapy (PDT) or oral eplerenone in chronic central serous chorioretinopathy (cCSC). Methods Multicentre randomized clinical trial included cCSC patients from the SPECTRA trial who were randomized to receive half‐dose PDT or oral eplerenone.
Helena M. A. Feenstra +8 more
wiley +1 more source
Current corticosteroid therapeutic strategy for community-acquired pneumonia in adults: indications, dosage, and timing. [PDF]
Fujishima S.
europepmc +1 more source
ABSTRACT Aims Hypertension and diabetes frequently coexist, yet the net clinical impact of intentionally combining antihypertensive (AHTN) and antidiabetic (ADA) therapies on cardiovascular (CV) outcomes is uncertain. Here we quantified the effects of AHTN and ADA co‐therapy on CV and blood pressure (BP)/heart rate (HR) outcomes.
Wan Chin Hsieh +2 more
wiley +1 more source
Special Issue: "Pharmacological Strategies and Molecular Mechanisms Associated with the Novel Nephroprotective Treatments". [PDF]
Provenzano M.
europepmc +1 more source

